Clinical Trial Update: Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial in Singapore is evaluating the safety of nucleoside reverse transcriptase inhibitors (NRTIs) for Alzheimer's disease in people with mil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Nucleoside reverse transcriptase inhibitors (NRTIs) (nucleoside reverse transcriptase inhibitors)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Mild Cognitive Impairment (MCI), Alzheimer Dementia (AD) | Phase 1 | Status: RECRUITING